drugset / Trial / NCT01144702
Effectiveness of the Association Artesunate and Mefloquine in the Treatment of Malaria by Plasmodium Falciparum
Phase 2/3
Completed
163 enrolled
Oswaldo Cruz Foundation
Ministry of Health, Brazil · collabPan American Health Organization · collabUniversity of Sao Paulo · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study was to evaluate the effectiveness of the fixed combination of artesunate+mefloquine in the treatment of uncomplicated malaria caused by Plasmodium falciparum in the municipality of Cruzeiro do Sul, Juruá Valley, Brazil, where it was being used as specific first-line drug.
Timeline
- Start
- 2010-11
- Primary completion
- 2013-04
- Completion
- 2014-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Artesunate | Small molecule | 4 mg/kg | Oral |
| Subject | Mefloquine | Unknown | 8 mg/kg | Oral |